Changes in Beneficial Ownership · 4
Xtant Medical Holdings, Inc.
XTNTNYSE_AMERICANEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
primary_doc.xml
Filing details
- Report period
- 2026-08-15
- Issuer
- Xtant Medical Holdings, Inc.
- Issuer CIK
- 0001453593
- Trading symbol
- XTNT
Reporting owner 1
- Name
- BAKEWELL JOHN K
- Reporting owner CIK
- 0001183553
- Relationship
- Director
- Address
- C/O XTANT MEDICAL HOLDINGS, INC., 664 CRUISER LANE, BELGRADE, MT, 59714
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-08-15 | A · Form 4 | 215,517[F1] | A | 0 | 1,129,633[F2] | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- These shares are subject to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on August 15, 2027, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.↩ 1
- F2
- Includes 681,087 shares issuable upon settlement of DSUs granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting date.↩ 1
Signature 1
- Signed
- /s/ Amy Culbert, attorney-in-fact
- Date
- 2026-08-18
Company context
We are a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Our products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine.